TipRanks
Go Ultimate55% OFF

Xilio Therapeutics (XLO) Balance Sheet

Xilio Therapeutics Balance Sheet

Xilio Therapeutics's total assets for Q2 2026 were $154.25M, a decrease of 5.65% from the previous quarter. XLO total liabilities were $81.99M for the fiscal quarter, a 9.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 154.69M$ 71.08M$ 60.93M$ 139.16M$ 221.60M
$ 119.41M$ 53.48M$ 24.10M$ 33.52M$ 36.17M
$ 35.27M$ 17.60M$ 36.83M$ 105.65M$ 185.43M

Currency in USD

Xilio Therapeutics Debt to Assets

080M160M240M0 %40 %80 %120 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets